A Translational Approach to Addressing COVID‑19
The process of developing new therapies and getting them to patients is long and difficult. During public health emergencies, science — and the process of turning observations into new therapies — must move faster than ever. That is where translational science comes in.
Translational science is focused on streamlining the process of moving (“translating”) lab findings into medical practice and treatments to improve health and well-being. NCATS is focused on advancing the science of translation.
NCATS is supporting research activities spanning the translational science spectrum to address the novel coronavirus 2019 (SARS-CoV-2) and the disease it causes (COVID‑19). With the aim of accelerating translational research across all diseases, NCATS has developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues.
In addition, by using its networks to draw together experts with necessary and complementary skills, knowledge and experience, NCATS is enabling projects to cut through operational roadblocks.
NCATS’ CTSA Program is helping to implement the ACTIV-6 clinical trial to evaluate the treatment of mild to moderate COVID-19 symptoms at home. Currently, researchers are enrolling participants to study the safety and effectiveness of Ivermectin.Learn More
Watch this video for a behind the scenes look at how a collaborative NIH study to measure undetected coronavirus cases came together.
A version of this video with audio description is available.
I Am Translational Science
This video series shares the stories of people working in translational science during the COVID‑19 pandemic. Watch the series.
Open NCATS opportunities: NCATS has issued several notices of special interest that highlight the urgent need for research on SARS-CoV-2 and COVID‑19. See all open NCATS funding opportunities.
Resources from the NIH Office of Extramural Research: COVID‑19 information for NIH applicants and recipients of NIH funding
Updates from Grantees and Partners
NCATS-supported researchers are actively working on a variety of efforts to address the pandemic.
See all grantee and partner updates.
COVID‑19 Resources from NIH and Other Federal Agencies
- Stay on top of the latest announcements and research information from NIH.
- Get public health updates and resources from the Centers for Disease Control and Prevention, including data and forecasts, information about symptoms and testing, and resources for stress and coping.
- Learn about the federal government response to COVID‑19.
- Use the Combat COVID website to find information about NIH late-phase prevention and treatment clinical trials, including several overseen by NCATS, for health care providers, people with COVID‑19 and people who have recovered from COVID‑19.
Banner Image Caption: Colorized scanning electron micrograph of a cell (purple) infected with SARS-CoV-2 virus particles (yellow), isolated from a patient sample. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID